• OPEN AN ACCOUNT
Indian Indices
Nifty
24,716.60 -34.10
(-0.14%)
Sensex
81,373.75 -77.26
( -0.09%)
Bank Nifty
55,903.40 153.70
( 0.28%)
Nifty IT
37,061.85 -259.90
( -0.70%)
Global Indices
Nasdaq
42,280.67 43.94
(0.10%)
Dow Jones
5,931.28 -1.89
(-0.03%)
Hang Seng
37,492.16 -472.94
(-1.25%)
Nikkei 225
8,772.38 55.93
(0.64%)
Forex
USD-INR
85.50 0.07
(0.09%)
EUR-INR
97.01 0.42
(0.44%)
GBP-INR
115.18 0.03
(0.03%)
JPY-INR
0.59 0.00
(0.53%)

EQUITY - MARKET SCREENER

Ambalal Sarabhai Enterprises Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500009
INE432A01017
5.880968
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AMBASARABH
22.81
290.21
EPS(TTM)
Face Value()
Div & Yield %
1.66
10
0
 

FDC consolidated net profit declines 16.44% in the March 2025 quarter
May 29,2025
Net profit of FDC declined 16.44% to Rs 38.67 crore in the quarter ended March 2025 as against Rs 46.28 crore during the previous quarter ended March 2024. Sales rose 6.46% to Rs 491.89 crore in the quarter ended March 2025 as against Rs 462.03 crore during the previous quarter ended March 2024.

For the full year,net profit declined 12.59% to Rs 266.79 crore in the year ended March 2025 as against Rs 305.22 crore during the previous year ended March 2024. Sales rose 8.50% to Rs 2108.12 crore in the year ended March 2025 as against Rs 1942.94 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales491.89462.03 6 2108.121942.94 9
OPM %10.9712.19 -15.4117.42 -
PBDT68.8775.64 -9 410.95436.13 -6
PBT53.3165.21 -18 357.22396.22 -10
NP38.6746.28 -16 266.79305.22 -13